Market Cap 150.36M
Revenue (ttm) 0.00
Net Income (ttm) -23.49M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 11,838,001
Avg Vol 1,376,354
Day's Range N/A - N/A
Shares Out 89.50M
Stochastic %K 6%
Beta 1.75
Analysts Strong Sell
Price Target $3.50

Company Profile

Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is zervimesine, an orally delivered small molecule to protect neuronal synapses by preventing the binding of oligomers of pathogenic proteins, which is in Phase 2 clinical studies for the treatment of Alzheimer's disease and Mi...

Industry: Biotechnology
Sector: Healthcare
Phone: 412 481 2210
Address:
2500 Westchester Ave., Purchase, United States
byeonkh
byeonkh Jun. 25 at 9:36 AM
$CGTX Many are blaming the mid-2026 timeline for the sell-off, but objectively it's roughly in line with expectations, maybe only slightly delayed. That's not enough to explain a nearly 40% collapse. The meeting minutes were overwhelmingly positive. DLB Phase 3 is essentially confirmed, and the NDA path remains intact. The fundamentals haven't weakened—they've become clearer. My view: a large ATM is the most likely reason behind this drop. We'll know soon enough. Good luck to all longs. $CGTX
1 · Reply
Ric_1M
Ric_1M Jun. 25 at 8:45 AM
$ADTX $ATLN $HTZ $TOYO $CGTX "Ever tried. Ever failed. No matter. Try again. Fail again. Fail better." Samuel Beckett
2 · Reply
BPSJazz
BPSJazz Jun. 25 at 4:36 AM
$CGTX - This is an interesting company. I'm buying.
0 · Reply
shmewdog
shmewdog Jun. 25 at 1:41 AM
$CGTX The market was speculating that we would get news of a partnership. This drop is way out of proportion. FDA is in alignment. Buying opportunity for long-term IMO, but probably a good idea to wait for some sort of recovery as who knows how low they can take it in the short term.
1 · Reply
Biopharma2021
Biopharma2021 Jun. 25 at 1:26 AM
$CGTX Bashers are out in force
1 · Reply
jiggs10
jiggs10 Jun. 24 at 11:36 PM
$CGTX looks to me like dilution n reverse split at some point. They laid an egg
5 · Reply
jiggs10
jiggs10 Jun. 24 at 11:34 PM
$CGTX This is going lower. They don't know how to run a company
0 · Reply
Ataifanboymentalhealthz
Ataifanboymentalhealthz Jun. 24 at 10:43 PM
$CGTX yah that’s the problem
0 · Reply
nottoday800
nottoday800 Jun. 24 at 10:35 PM
$CGTX this will go bacj under .65 ill get some then
0 · Reply
CraigGarrett
CraigGarrett Jun. 24 at 10:03 PM
$CGTX surely this is because they have diluted shares and sold a bunch today, right? There is no reason other than that for the stock to drop this much in a single day. The investor relations for this company had better tell us what the hell is going on. I am a long-term investor and I am pissed.
2 · Reply
Latest News on CGTX
Cognition Therapeutics gets FDA feedback on zervimesine study

2026-06-24T11:40:14.000Z - 22 hours ago

Cognition Therapeutics gets FDA feedback on zervimesine study


Cognition Therapeutics Transcript: AGM 2026

Jun 17, 2026, 9:00 AM EDT - 7 days ago

Cognition Therapeutics Transcript: AGM 2026


Cognition Therapeutics Slides: Investor presentation

Jun 4, 2026, 7:00 AM EDT - 20 days ago

Cognition Therapeutics Slides: Investor presentation


Cognition Therapeutics conducts zervimesine meeting with FDA

2026-05-21T11:48:47.000Z - 4 weeks ago

Cognition Therapeutics conducts zervimesine meeting with FDA


Cognition Therapeutics reports Q1 EPS (5c), consensus (7c)

2026-05-07T23:09:07.000Z - 6 weeks ago

Cognition Therapeutics reports Q1 EPS (5c), consensus (7c)


Cognition Therapeutics Earnings release: Q1 2026

May 7, 2026, 4:00 PM EDT - 6 weeks ago

Cognition Therapeutics Earnings release: Q1 2026


Cognition Therapeutics Quarterly report: Q1 2026

May 7, 2026, 4:00 PM EDT - 6 weeks ago

Cognition Therapeutics Quarterly report: Q1 2026


Cognition Therapeutics Proxy statement: Proxy filing

Apr 27, 2026, 8:00 AM EDT - 2 months ago

Cognition Therapeutics Proxy statement: Proxy filing


Cognition Therapeutics Proxy statement: Proxy filing

Apr 27, 2026, 8:00 AM EDT - 2 months ago

Cognition Therapeutics Proxy statement: Proxy filing


Cognition Therapeutics CEO Issues Letter to Shareholders

Mar 31, 2026, 4:30 PM EDT - 3 months ago

Cognition Therapeutics CEO Issues Letter to Shareholders


Cognition Therapeutics Earnings Call Transcript: Q4 2025

Mar 26, 2026, 8:30 AM EDT - 3 months ago

Cognition Therapeutics Earnings Call Transcript: Q4 2025


Cognition Therapeutics Earnings release: Q4 2025

Mar 26, 2026, 8:30 AM EDT - 3 months ago

Cognition Therapeutics Earnings release: Q4 2025


Cognition Therapeutics Annual report: Q4 2025

Mar 26, 2026, 8:30 AM EDT - 3 months ago

Cognition Therapeutics Annual report: Q4 2025


Cognition Therapeutics Slides: Corporate presentation

Mar 26, 2026, 8:00 AM EDT - 3 months ago

Cognition Therapeutics Slides: Corporate presentation


Cognition Therapeutics extends duration of EAP for zervimesine

2026-02-05T12:35:13.000Z - 4 months ago

Cognition Therapeutics extends duration of EAP for zervimesine


Cognition publishes Phase 2 results on Zervimesine

2026-01-06T12:41:42.000Z - 6 months ago

Cognition publishes Phase 2 results on Zervimesine


Cognition Therapeutics files $300M mixed securities shelf

2025-12-18T21:15:25.000Z - 6 months ago

Cognition Therapeutics files $300M mixed securities shelf


Cognition Therapeutics reports Q3 EPS (6c), consensus (9c)

2025-11-06T12:41:38.000Z - 8 months ago

Cognition Therapeutics reports Q3 EPS (6c), consensus (9c)


Cognition Therapeutics Quarterly report: Q3 2025

Nov 6, 2025, 7:30 AM EST - 8 months ago

Cognition Therapeutics Quarterly report: Q3 2025


Cognition Therapeutics Earnings release: Q3 2025

Nov 6, 2025, 7:30 AM EST - 8 months ago

Cognition Therapeutics Earnings release: Q3 2025


Cognition Therapeutics regains compliance with Nasdaq

2025-08-26T20:05:36.000Z - 10 months ago

Cognition Therapeutics regains compliance with Nasdaq


Cognition Therapeutics reports Q2 EPS (11c), consensus (10c)

2025-08-07T20:10:27.000Z - 11 months ago

Cognition Therapeutics reports Q2 EPS (11c), consensus (10c)


Cognition Therapeutics Earnings release: Q2 2025

Aug 7, 2025, 4:00 PM EDT - 11 months ago

Cognition Therapeutics Earnings release: Q2 2025


Cognition Therapeutics Quarterly report: Q2 2025

Aug 7, 2025, 4:00 PM EDT - 11 months ago

Cognition Therapeutics Quarterly report: Q2 2025


Cognition Therapeutics Quarterly report: Q1 2025

May 7, 2025, 7:30 AM EDT - 1 year ago

Cognition Therapeutics Quarterly report: Q1 2025


Cognition Therapeutics Earnings release: Q1 2025

May 7, 2025, 7:30 AM EDT - 1 year ago

Cognition Therapeutics Earnings release: Q1 2025


Cognition Therapeutics Proxy statement: Proxy Filing

Apr 28, 2025, 8:00 AM EDT - 1 year ago

Cognition Therapeutics Proxy statement: Proxy Filing


Cognition Therapeutics Proxy statement: Proxy Filing

Apr 28, 2025, 8:00 AM EDT - 1 year ago

Cognition Therapeutics Proxy statement: Proxy Filing


Cognition Therapeutics Earnings Call Transcript: Q4 2024

Mar 20, 2025, 8:00 AM EDT - 1 year ago

Cognition Therapeutics Earnings Call Transcript: Q4 2024


Cognition Therapeutics Earnings release: Q4 2024

Mar 20, 2025, 8:00 AM EDT - 1 year ago

Cognition Therapeutics Earnings release: Q4 2024


Cognition Therapeutics Annual report: Q4 2024

Mar 20, 2025, 8:00 AM EDT - 1 year ago

Cognition Therapeutics Annual report: Q4 2024


Cognition Therapeutics Transcript: Study Result

Dec 18, 2024, 8:00 AM EST - 1 year ago

Cognition Therapeutics Transcript: Study Result


Cognition Therapeutics Press release: Study Result

Dec 18, 2024, 8:00 AM EST - 1 year ago

Cognition Therapeutics Press release: Study Result


Cognition Therapeutics Transcript: Life Sciences Investor Forum

Nov 14, 2024, 11:00 AM EST - 1 year ago

Cognition Therapeutics Transcript: Life Sciences Investor Forum


Cognition Therapeutics Quarterly report: Q3 2024

Nov 13, 2024, 7:30 AM EST - 1 year ago

Cognition Therapeutics Quarterly report: Q3 2024


Cognition Therapeutics Earnings release: Q3 2024

Nov 13, 2024, 7:30 AM EST - 1 year ago

Cognition Therapeutics Earnings release: Q3 2024


byeonkh
byeonkh Jun. 25 at 9:36 AM
$CGTX Many are blaming the mid-2026 timeline for the sell-off, but objectively it's roughly in line with expectations, maybe only slightly delayed. That's not enough to explain a nearly 40% collapse. The meeting minutes were overwhelmingly positive. DLB Phase 3 is essentially confirmed, and the NDA path remains intact. The fundamentals haven't weakened—they've become clearer. My view: a large ATM is the most likely reason behind this drop. We'll know soon enough. Good luck to all longs. $CGTX
1 · Reply
Ric_1M
Ric_1M Jun. 25 at 8:45 AM
$ADTX $ATLN $HTZ $TOYO $CGTX "Ever tried. Ever failed. No matter. Try again. Fail again. Fail better." Samuel Beckett
2 · Reply
BPSJazz
BPSJazz Jun. 25 at 4:36 AM
$CGTX - This is an interesting company. I'm buying.
0 · Reply
shmewdog
shmewdog Jun. 25 at 1:41 AM
$CGTX The market was speculating that we would get news of a partnership. This drop is way out of proportion. FDA is in alignment. Buying opportunity for long-term IMO, but probably a good idea to wait for some sort of recovery as who knows how low they can take it in the short term.
1 · Reply
Biopharma2021
Biopharma2021 Jun. 25 at 1:26 AM
$CGTX Bashers are out in force
1 · Reply
jiggs10
jiggs10 Jun. 24 at 11:36 PM
$CGTX looks to me like dilution n reverse split at some point. They laid an egg
5 · Reply
jiggs10
jiggs10 Jun. 24 at 11:34 PM
$CGTX This is going lower. They don't know how to run a company
0 · Reply
Ataifanboymentalhealthz
Ataifanboymentalhealthz Jun. 24 at 10:43 PM
$CGTX yah that’s the problem
0 · Reply
nottoday800
nottoday800 Jun. 24 at 10:35 PM
$CGTX this will go bacj under .65 ill get some then
0 · Reply
CraigGarrett
CraigGarrett Jun. 24 at 10:03 PM
$CGTX surely this is because they have diluted shares and sold a bunch today, right? There is no reason other than that for the stock to drop this much in a single day. The investor relations for this company had better tell us what the hell is going on. I am a long-term investor and I am pissed.
2 · Reply
Tyler66
Tyler66 Jun. 24 at 9:41 PM
$CGTX somebody please Take The hatchet out of Back ghezzzz bloody Wednesday, see this is why you have to look at it every day I think my heart just fell on my stomach
0 · Reply
Aimforsuccess
Aimforsuccess Jun. 24 at 9:06 PM
$CGTX Fantastic news in my opinion and the market makers take it down to let institutions buy, in my opinion. A registration trial set with plenty of time to choose a partner or acquirer. Don’t ever forget our CEO’s record on sell outs of companies where she has worked.
0 · Reply
Vinnie77
Vinnie77 Jun. 24 at 8:57 PM
$CGTX disappointing reaction today, but a chance to buy some at low prices so I’m not that bothered. I have time to see this come to the appropriate levels
1 · Reply
mcclayjd40
mcclayjd40 Jun. 24 at 8:51 PM
$CGTX I suppose I’m deranged but I think something unforeseen is coming in the near future and it’s going to be very positive for this company. Just a gut feeling. We’ ll see.
1 · Reply
History101
History101 Jun. 24 at 8:22 PM
$CGTX well that sucked
1 · Reply
Tech2026
Tech2026 Jun. 24 at 8:01 PM
$CGTX Not good, MM are in control. Will ride this storm!!
1 · Reply
Goodhealth
Goodhealth Jun. 24 at 7:44 PM
$CGTX My take on the current situation is that Cognition is already in negotiations with potential partners. The company's negotiating potion is better with a long time horizon that they can adhere to if they do not get an agreement with one or more partners. This also shows potential partners that Cognition is not in a panic and has several options... Just my perception of the situation.
4 · Reply
Biopharma2021
Biopharma2021 Jun. 24 at 7:41 PM
$CGTX criminal cartel market makers manipulating the price
0 · Reply
Johnnie_Parlay
Johnnie_Parlay Jun. 24 at 7:22 PM
$CGTX cautiously
0 · Reply
Marshallmathers1
Marshallmathers1 Jun. 24 at 7:20 PM
$CGTX 40% drop seems excessive. Buying more
0 · Reply
Marshallmathers1
Marshallmathers1 Jun. 24 at 7:19 PM
$CGTX Jfc…☹️
0 · Reply
GibsonFlyingV
GibsonFlyingV Jun. 24 at 7:14 PM
$CGTX nothing has changed. And anyone with any idea of what’s going on is holding this until well into 2027. This isn’t a day flip for little Kyle and his supreme hat with his monster energy drink and his vape pen with four computer screens in front of him. This one is for real. The price action we saw last two weeks wasn’t meant to last.
0 · Reply